GRASTIM 300MCG/ML

What is GRASTIM 300MCG/ML?

GRASTIM 300MCG/ML is an injectable medicine containing Filgrastim, a recombinant human granulocyte colony-stimulating factor (G-CSF). It stimulates the bone marrow to produce neutrophils, which are essential white blood cells that fight infections.

It is commonly used in patients with chemotherapy-induced neutropenia, bone marrow transplantation, or chronic neutropenia to reduce infection risk.

What is the use of GRASTIM 300MCG/ML?

• To prevent or treat neutropenia caused by chemotherapy.

• To reduce infection risk in patients with low white blood cells.

• To mobilize hematopoietic stem cells for transplantation procedures.

Benefits of GRASTIM 300MCG/ML:

• Boosts neutrophil counts to enhance immune defense.

• Helps patients tolerate chemotherapy by reducing infection risk.

• Supports faster recovery of white blood cells after chemotherapy.

• Can be used for stem cell mobilization for transplantation.

Side Effects of GRASTIM 300MCG/ML:

• Common: Bone or muscle pain, headache, mild fever, fatigue, injection site reactions.

• Rare/Serious: Splenomegaly or spleen rupture, severe allergic reactions, low platelet count.

Note: Blood counts and spleen monitoring are recommended during therapy.

Dosage and Administration:

• Administered subcutaneously or intravenously as prescribed.

• Dose depends on body weight, type of chemotherapy, and neutrophil counts.